Chinese Drugmakers Hit Record US$136 Billion in Global Licensing Deals in 2025

Chinese pharmaceutical companies signed a record US$136 billion worth of out licensing agreements in 2025, underscoring the rapid rise of China as a major source of innovative drug development and reshaping the global biopharmaceutical landscape. According to industry analysts, the total value of